On the cheapBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39108.530150.B7 (Published 01 February 2007) Cite this as: BMJ 2007;334:262
- Ike Iheanacho, editor, Drug and Therapeutics Bulletin (email@example.com)
Like much else in health care in Britain, attempts to prescribe drugs by generic rather than brand names can be frustrating. This crucial contribution to containing the national drugs bill is sometimes disrupted by the tactics of the drug industry. And it must be rare to find patients who actively welcome being switched from a product with a familiar name and look.
Despite these negative aspects, the prescribing of generic drugs is a success story in the UK and should be cause for celebration. That it isn't celebrated (at least, …